Previous close | 8.65 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | 5.604M |
Beta (5Y monthly) | 0.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.32 |
Earnings date | 15 Mar 2023 - 20 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
If you are looking for stocks that are well positioned to maintain their recent uptrend, CymaBay Therapeutics Inc. (CBAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Insiders who bought CymaBay Therapeutics, Inc. ( NASDAQ:CBAY ) stock lover the last 12 months are probably not as...
Here is how Gilead Sciences (GILD) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.